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ABSTRACT
Objective: To evaluate the effect of intrusive thoughts at diagnosis on quality of life, depressed mood
and waking up with anxiety up to two years after radical prostatectomy.
Method: The Laparoscopic Prostatectomy Robot Open (LAPPRO) trial was a prospective, longitudinal
multicenter study of 4003 patients undergoing radical prostatectomy. Questionnaire data were col-
lected preoperatively, at 3, 12 and 24months after surgery.
Results: The group of patients with intrusive thoughts at diagnosis had a statistically significant higher
postoperative prevalence of impaired quality of life, depressed mood and waking up with anxiety as
compared with the group of patients with no or minor intrusive thoughts. The highest risk increase
for impaired QoL, depressed mood and waking up with anxiety 1/week was at 12, 3 and 3months,
respectively, where the three outcomes increased by 38% (RR: 1.38; 95%CI: 1.27–1.49)), 136% (RR: 2.36;
95%CI: 1.74–3.19)) and 165% (RR: 2.65; 95%CI: 2.22–3.17)), respectively.
Conclusions: The demonstrated link between intrusive thoughts and quality of life, depressed mood
and waking up with anxiety deliver is further evidence to the idea that intrusive thoughts has poten-
tial as an endpoint for assessing and predicting psychological distress among men with prostate can-
cer diagnosis.
Trial registration number: ISRCTN06393679 (www.isrctn.com). Date of registration: 07/02/2008.
Retrospectively registered.
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Introduction
Prostate cancer is the second most frequently diagnosed
cancer and the fifth leading cause of cancer death in men
worldwide [1]. Established risk factors are age, family history
and ethnicity [2]. Facing a diagnosis of a life-threating dis-
ease such as prostate cancer is a life-changing trauma which
may render a flood of emotions and thoughts that can be
difficult to handle for the patient. According to the social-
cognitive processing model [3], a traumatic event such as a
cancer diagnosis is distressing because it challenges preexist-
ing views of the self and the world [4]. By cognitively proc-
essing the trauma, the patient can accept and being able to
deal with the diagnosis and thereby reduce the distress.
Being able to be emotionally expressive in a supportive
social environment is one important part of this pro-
cess [3,5].
Intrusive thoughts are unintentional recurrent and dis-
tressing thoughts about things one does not intend to think
about, such as the cancer diagnosis [6]. These thoughts can
be seen as part of the acceptance cognitive process as they,
in theory, emerge from the patients urge to integrate infor-
mation associated with the diagnosis into their mental mod-
els [3,4]. Intrusive thoughts are from this perspective a sign
of an ongoing or incomplete cognitive process and could be
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seen as a symptom relating to reduced psychological well-
being [6].
For successful management of distress it is necessary to
assess reasonable structures of the causal relationships
between different factors, such as intrusive thoughts and
social constrains (barriers to emotional expression) associated
with psychological well-being that is to identify the direc-
tions of the causal pathways. Whereas a majority of the stud-
ies seeking to explore the different associations have been
cross-sectional and of moderate size [5,7,8], some have been
longitudinal [9,10]. One of these, the Laparoscopic
Prostatectomy Robot Open (LAPPRO) trial, involved an in-
depth assessment of psychological well-being using ques-
tionnaires extensively validated among patients with prostate
cancer [10]. In this study, Thorsteinsdottir [6] found associa-
tions between intrusive thoughts at diagnosis and Quality of
Life (QoL), depressed mood and waking up in the middle of
the night with anxiety both at diagnosis as well as three
months after radical prostatectomy. The analyses were
unadjusted for confounders and were done while patient
enrollment was ongoing and therefore only included one-
third of the final cohort.
The aim of this study was to evaluate the effect of pre-
operative intrusive thoughts at diagnosis on quality of life,
depressed mood and waking up with anxiety up to two
years after radical prostatectomy in an adjusted analysis of
the full cohort.
Materials and methods
Laparoscopic Prostatectomy Robot Open (LAPPRO) is an
open-label, multi-center, non-randomized prospective longi-
tudinal trial [10] (trial registration number: ISRCTN06393679).
Inclusion criteria were ability to read and write Swedish, writ-
ten informed consent, tumour stage cT1, cT2, or cT3, and no
signs of distant metastases. The trial was approved by the
regional ethics review board in Gothenburg (277-07). The
study is ongoing with a recent eight-year follow-up. The
patients completed paper questionnaires at the time of
admission for surgery at the hospital and at home
31,224months after surgery. The primary objective of the
study is to compare two surgical techniques in radical pros-
tatectomy for prostate cancer (open retropubic and robot-
assisted laparoscopic) with regard to self-reported urinary
incontinence and erectile dysfunction.
Questionnaires
Questionnaires are generally said to be developed within the
psychometric and clinimetric frameworks. Psychometrics
broadly refers to the measurement of psychological con-
structs such as personality traits, for example intelligence,
and dates back to the nineteenth century [11]. Clinimetrics is
a term introduced in the 1980s to define methods for assess-
ing clinical phenomena, such as symptoms [12,13]. Even
though there is no clear distinction between the two
approaches, they can be broadly viewed as serving different
purposes: Whereas psychometrics aims at optimally
measuring a single construct such as depression using mul-
tiple items, the clinimetric approach seeks to establish items
that can characterize various aspects of the construct (attri-
bute) of interest, such as prevalence, intensity and associated
distress [14,15]. For conceptual clarity, one symptom at a
time is considered, excluding scales in which items are sum-
marized [15]. The questionnaire used in LAPPRO was based
on the clinimetric approach.
The questionnaire development was made as follows.
Starting with existing questionnaires from similar studies
[16], new study-specific questions were developed based on
in-depth interviews with patient with prostate cancer, which
was followed by contents analysis of what they reported.
The questionnaires were subsequently contents validated by
clinical experts and validated face-to-face with prostate can-
cer patients (an investigator accompanied them while com-
pleting the questionnaire and assessed their understanding
of the items) and tested in a pilot study of 100 men with
subsequent revisions, as described by Thorsteinsdottir et al.
[10]. The questions on intrusive thoughts, QoL, depressed
mood and waking up with anxiety grew out of the work of
Thorsteinsdottir, Valdimarsdottir and Steineck [10,17]. This
concept of validation has been used extensively in several
studies [18–21] within the Scandinavian Surgical Outcomes
Research Group (SSORG).
Variables
Negative intrusive thoughts and the outcome variables QoL,
depressed mood and waking up with anxiety were dicho-
tomized in the same way as in previous analyses in the
LAPPRO trial [6,22]. Negative intrusive thoughts (hereafter
‘Intrusive thoughts’) were addressed by ‘How often during the
past month have you had negative thoughts about your
prostate cancer, suddenly and unintentionally?’ The response
options were: 1 ‘Never’, 2 ‘More seldom than once a week’, 3
‘At least once a week’, 4 ‘At least three times a week’, 5 ‘At
least once a day’, 6 ‘At least three times a day’ and 7 ‘At
least seven times a day’. Responses were dichotomized with
less than once per week (categories 1 and 2) as cut-off. ‘How
would you describe your quality of life during the past
month?’, with response according to a visual analogue scale
anchored by 0 meaning ‘No quality of life’ and 6 ‘Best pos-
sible quality of life’. Responses were dichotomized with a
cut-off point between 4 (0–4: low/moderate) and 5 (5–6:
good/very good), where the former indicates an impaired
quality of life. Depressed mood was evaluated by ‘Would you
call yourself depressed?’, with response options 1 ‘Yes’ and 2
‘No’. A similar item, ‘Are you depressed?’ has previously been
shown to identify patients who are not depressed [19].
Waking up with anxiety was detailed by the question: ‘Have
you in the past month woken up in the night with nervous-
ness, anxiety or feeling of discomfort?’ with the response cat-
egories: 1 ‘No’, 2 ‘Yes, but more seldom than once a week’, 3
‘Yes, at least once a week’, 4 ‘Yes, at least three times a
week’, 5 ‘Yes, every night’. Responses were dichotomized
with less than once per week (categories 1 and 2) as cut-off.
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The variables used for adjustment (age at diagnosis,
American Society of Anesthesiologists (ASA) classification,
alcohol consumption, comorbidity, cohabiting, education,
postoperative bother due to urinary or erectile dysfunction
and biochemical recurrence) in the adjusted statistical analy-
ses were chosen based on clinical judgement and previous
study results [22–24]. Details on all variables are presented in
the Supplement Table S1.
Statistical analysis
The prevalence of impaired QoL, depressed mood and wak-
ing up with anxiety preoperatively and 3, 12, and 24months
postoperatively was estimated by a marginal binomial model
with identity link, intrusive thoughts at diagnosis, time and
the interaction (intrusive thoughts time) as fixed effects.
The intra-subjects dependence (i.e. due to subject specific
effects on the outcome) was accounted for by using general-
ized estimating equations (GEE) for parameter estimation
with an empirical ‘sandwich’ estimator of the standard errors
[25]. Results were presented graphically as prevalence esti-
mates and 95%CI.
The effect of intrusive thoughts on the outcome variables
at 3, 12 and 24months after surgery was evaluated using
both unadjusted and adjusted analyses. The adjusted analysis
with a binomial distribution encountered convergence prob-
lems during the iterative parameter estimation. Therefore the
modified Poisson regression approach by Zou [26] was used
where intrusive thoughts at diagnosis, time and the inter-
action and the variables used for adjustment was included as
fixed effects. In a marginal model the estimator of the differ-
ence intrusive thoughts 1/week vs <1/week targets the
expected difference in outcomes between the population
with 1/week and <1/week, respectively. This is in contrast
with the random effects model which estimates the corre-
sponding difference conditional on the subject specific
effects which enables estimation of individual effects [25,27].
In order to avoid list-wise deletion due to missing values
in the variables used for adjustment, multiple imputations
with chained equations (MICE) were used to generate 50
data sets with imputed data [28]. Parameter estimates were
pooled from the 50 datasets and the effects of intrusive
thoughts were presented as risk ratios (RR), 95%CIs and p-
values. The SAS procedures GENMOD, MI and MIANALYZE
were used for the statistical analyses SAS 9.4 (SAS Institute,
Cary, NC) and R package ggplot [29] was used for graphics.
Results
In total, 4003 patients were enrolled in LAPPRO from 1
September 2008 to 7 November 2011 (Figure 1). For the
3706 eligible patients, the response rate for the question on
preoperative intrusive thoughts was 3237 (87%). Response
rate for questions related to the outcomes ranged from 90%
to 97% (Figure 1). Patient characteristics are presented in
Table 1.
Preoperatively 1170 (36%) of the patients had intrusive
thoughts 1/week. Age, civil status, educational level and
residence were not significantly different among patients
with intrusive thoughts <1/week and 1/week. Patients with
intrusive thoughts 1/week had preoperatively worse QoL
(66% vs 35%), had more often depressed mood (15% vs 4%)
and waking up with anxiety (47% vs 11%) and lower self-
esteem (16% vs 4%). The preoperative bother due to urinary
and erectile dysfunction did not differ.
While postoperative QoL and waking up with anxiety
improved over time in both groups, depressed mood was
stable (Figure 2). The group of patients with preoperative
intrusive thoughts 1/week had a statistically significant
higher prevalence of impaired QoL, depressed mood and
waking up with anxiety 1/week as compared with the
group of patients with intrusive thoughts <1/week, see
Table 2. The highest risk increase for impaired QoL,
depressed mood and waking up with anxiety 1/week was
Figure 1. Flow chart of patients included in the study.
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at 12, 3 and 3months, respectively, where the three out-
comes increased 38% (RR: 1.38; 95%CI: 1.27–1.49), 136% (RR:
2.36; 95%CI: 1.74–3.19) and 165% (RR: 2.65; 95%CI:
2.22–3.17), respectively.
Discussion
In this prospective trial, we evaluated the effect of preopera-
tive intrusive thoughts on quality of life, depressed mood
and waking up with anxiety up to two years after radical
prostatectomy. The results showed that there is an associ-
ation between intrusive thoughts and quality of life,
depressed mood and waking up with anxiety. Our study
strengthened the previously found link between intrusive
thoughts and the studied outcomes [6] as we studied a
larger cohort, have longer follow-up and addressed causality
by adjusted analyses.
From the perspective that intrusive thoughts is a sign of
an ongoing or incomplete cognitive processing and could be
Table 1. Patient characteristics.
Intrusive thoughts at baseline
Missing/
Variable Outcome <1/week (N¼ 2067) 1/week (N¼ 1170) not missing
Age (years) Median (Q1; Q2) 64(60; 68) 63(58; 66) 0/3237
Cohabiting Living with partner 1741/2052(85) 972/1163(84) 22/3215
Living without partner 311/2052(15) 191/1163(16)
Education Not university 1293/2051(63) 694/1165(60) 21/3216
University 758/2051(37) 471/1165(40)




Alcohol consumption: Drinking > 6 glasses at the same occasion  1/week 87/2044(4) 97/1159(8) 34/3203
< 1/week 1957/2044(96) 1062/1159(92)
Being physical active in at least 30minutes At most 1–2/week 705/2056(34) 479/1166(41) 15/3222
At least 3–4/week 1351/2056(66) 687/1166(59)
Comorbiditya No 1052/2067(51) 534/1170(46) 0/3237
Yes 1015/2067(49) 636/1170(54)
Quality of life last month High QoL 1336/2055(65) 392/1167(34) 15/3222
Low QoL 719/2055(35) 775/1167(66)
Depressed mood No 1972/2059(96) 990/1169(85) 9/3228
Yes 87/2059(4) 179/1169(15)
Waking up with anxiety last month < 1/week 1825/2059(89) 618/1166(53) 9/3228
 1/week 234/2059(11) 548/1166(47)
Felt down last month Always 87/2059(4) 179/1169(15) 9/3228
Never 1972/2059(96) 990/1169(85)
Periods with intense anxiety last month < 1/week 2042/2066(99) 1033/1169(88) 2/3235
 1/week 24/2066(1) 136/1169(12)
Someone to talk about anxiety with No 127/2050(6) 77/1163(7) 24/3213
Yes 1923/2050(94) 1086/1163(93)
Level of selfesteem last month Moderate/high 1971/2052(96) 972/1163(84) 22/3215
None/low 81/2052(4) 191/1163(16)
Bother with overall difficulties to urinate Minor bother 495/2048(24) 321/1159(28) 30/3207
No bother or N/A 1080/2048(53) 545/1159(47)
Severe bother 473/2048(23) 293/1159(25)
Bother with erectile dysfunction Minor bother 260/1976(13) 104/1140(9) 121/3116
No bother or N/A 707/1976(36) 394/1140(35)
Severe bother 1009/1976(51) 642/1140(56)
ASA I 1298/2019(51) 754/1138(66) 80/3157
II 672/2019(33) 368/1138(32)
IV 492019(2) 16/1138(1)
Pre-op PSA (ng/mL) 0–4.4 ng/mL 474/2065(23) 294/1167(25) 5/3232
4.5–6.1 ng/mL 543/2065(26) 283/1167(24)
6.2–9.1 ng/mL 528/2065(26) 283/1167(24)
9.2– ng/mL 520/2065(25) 307/1167(26)
Pre-op PSA alt (ng/mL) 0–10 ng/mL 1650/2065(80) 910/1167(78) 5/3232
10–20 ng/mL 415/2065(20) 257/1167(22)
Surgical method ORP 473/2067(23) 331/1170(28)
RALP 1594/2067(77) 839/1170(72)
Prostate weight(g) 0–19 g 14/2036(1) 9/1160(1) 41/3196
20–39 g 739/2036(36) 502/1160(43)
40–59 g 889/2036(44) 479/1160(41)
60–79 g 259/2036(13) 128/1160(11)
80þ g 135/2036(7) 42/1160(4)
Pathology tumour stage T2 1478/2020(73) 804/1150(70) 67/3170
T3 529/2020(26) 340/1150(30)
T4 13/2020(1) 6/1150(1)
Prostatectomy specimen Gleason score 7 1918/2037(94) 1060/1156(92) 44/3193
>7 119/2037(6) 96/1156(8)
aComorbidity is defined as responding ‘yes’ to at least one of questions regarding stroke, thrombosis, neurological disease, diabetes, hypertension, myocardial
infarction, angina, heart failure, COPD, gastric ulcer, kidney disease, depression, inguinal hernia or prostatitis.
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seen as a symptom relating to anxiety and depressive mood,
self-assessed intrusive thoughts could potentially be a surro-
gate endpoint for use in evaluating interventions aiming for
reducing distress. Expressive writing has been suggested as
an intervention aimed to promote wellbeing by facilitating
emotional and cognitive processes [30]. In a typical writing
session, as instructed by the urologist or urology nurse, the
patient write about their deepest thoughts and feelings
related to the experience of having prostate cancer during
approximately 20min, 3–4 times per week, see [31] and the
references therein. The efficiency of expressive writing is
however unclear [30,31]. However, as Zachariae and O’Toole
[30] put it, due to the feasibility of the intervention, even
small treatment effects in subgroups of patients could be
clinically relevant. In a report by Siemsen [32], expressive
writing was found to moderate the effects of social con-
straints on intrusive thoughts among patients with prostate
cancer, i.e. expressive writing could potentially be effective in
a subgroup of patients experiencing constraints on their
emotional disclosure. Regardless, the high prevalence
indicates there is an unmet need to treat intrusive thoughts:
Preoperatively the prevalence was 36% and 20% after
24months as reported in Bock [22], which is similar to a
prevalence of 21% observed in a sample of the Swedish gen-
eral population [33].
It is, as previously mentioned, important to establish the
causal pathways between the different factors associated
with psychological well-being. Social constrains has been
associated both with distress [34,35] and intrusive thoughts
[17,23] and Kollberg et al. [23] and Lepore et al. [34] suggest
intrusive thoughts being a mediator between social con-
straints and psychological well-being. Whereas suffering from
an initial depression may well increase the risk for intrusive
thoughts, the proposed pathway appear to involve
depressed mood as well [36,37]. Fear of cancer recurrence
has also been identified as a risk factor for impaired QoL
[38–40]. Thorsteinsdottir et al. [24] identified preoperative
uncertainty of cure, alcohol consumption, physical health,
antidepressant medication, not being prepared for urinary
symptoms, age and physical pain as risk factors for intrusive
Figure 2. Risk (%) with 95% confidence intervals, preoperatively and 3, 12 and 24months postoperatively.
Table 2. Prevalence of endpoints and estimated effect of intrusive thoughts at baseline.
Follow-up
Intrusive thoughts at diagnosis Ratio (  1/week vs< 1/week) (95% CI)
Endpoint (months) Outcome  1/week (N¼ 1170) < 1/week (N¼ 2067) Unadjusted Adjusted, MIa p-valuea
QoL 3 Low 755/1134(67) 925/1990(46) 1.43(95%CI: 1.35–1.52) 1.29(95%CI: 1.21–1.37) <.0001
High 379/1134(33) 1065/1990(54)
12 Low 593/1083(55) 698/1949(36) 1.53(95%CI: 1.41–1.66) 1.38(95%CI: 1.27–1.49) <.0001
High 490/1083(45) 1251/1949(64)
24 Low 579/1061(55) 738/1906(39) 1.41(95%CI: 1.3–1.52) 1.27(95%CI: 1.17–1.37) <.0001
High 482/1061(45) 1168/1906(61)
Depressed mood 3 Yes 109/1130(10) 62/1991(3) 3.1(95%CI: 2.29–4.19) 2.36(95%CI: 1.74–3.19) <.0001
No 1021/1130(90) 1929/1991(97)
12 Yes 92/1078(9) 56/1943(3) 2.96(95%CI: 2.14–4.09) 2.32(95%CI: 1.69–3.19) <.0001
No 986/1078(91) 1887/1943(97)
24 Yes 84/1054(8) 64/1901(3) 2.37(95%CI: 1.73–3.25) 1.88(95%CI: 1.37–2.57) .0002
No 970/1054(92) 1837/1901(97)
Wake up with anxiety 3  1/week 286/1136(25) 162/1997(8) 3.10(95%CI: 2.60–3.71) 2.65(95%CI: 2.22–3.17) <.0001
< 1/week 850/1136(75) 1835/1997(92)
12  1/week 230/1086(21) 140/1955(7) 2.96(95%CI: 2.43–3.60) 2.53(95%CI: 2.08–3.08) <.0001
< 1/week 856/1086(79) 1815/1955(93)
24  1/week 247/1060(23) 157/1911(8) 2.84(95%CI: 2.36–3.41) 2.43(95%CI: 2.02–2.92) <.0001
< 1/week 813/1060(77) 1754/1911(92)
aAdjusted for age, alcohol consumption, comorbidity, ASA, educational and marital status, bother due to urinal and sexual dysfunction and biochemical recur-
rence. Missing values on adjustment variables handled by multiple imputations.
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thoughts. Preoperative levels of alcohol consumption was
also found in Bock [22] associated with elevated risk of intru-
sive thoughts of up to two years after surgery. In an earlier
publication of Thorsteinsdottir et al. [6] associations were
found between intrusive thoughts at diagnosis and Quality
of Life (QoL), depressed mood and waking up in the middle
of the night with anxiety both at diagnosis as well as three
months after radical prostatectomy.
The marginal statistical model estimates the expected dif-
ference in outcome between intrusive thoughts 1/week
and <1/week on a population level. This is in contrast to the
random effects model that can make statements on the dif-
ference on a subject level. The choice of model depends on
the scientific question raised and have implications on the
clinical interpretation. The former model addresses question
in line with a public health perspective; how much will the
population prevalence of impaired QoL be reduced by a
treatment against intrusive thoughts? The latter model
answers questions like: whats the chance of improving a cer-
tain patients QoL by reducing his intrusive thoughts? An in-
depth methodological discussion is beyond the scope of this
article but there is an extensive debate on the pros and cons
of the different approaches [41,42].
A limitation is the non-randomized design and lack of
data prior to diagnosis. Another limitation is that we cannot
fully establish to which extent the causality goes in reverse
direction from distress to intrusive thoughts. A third is the
that since the study is limited to patients undergoing prosta-
tectomy and patients with more advanced disease were
excluded we were not able to account for the relationship
between more advanced prostate cancer and and psychiatric
illness that has been previously observed [43,44], nor to com-
pare with patients undergoing radiotherapy.
Intrusive thoughts predict quality of life, depressed mood
and waking up with anxiety among patients diagnosed with
prostate cancer. This strengthens the evidence that intrusive
thoughts have potential as an endpoint for assessing psycho-
logical distress which is of importance in clinical practice and
well as in the design of clinical trials.
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